Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC), Nonsmall Cell Lung Cancer, Stage IIIB, Nonsmall Cell Lung Cancer, Stage IV
In brief
This study aimed to evaluate the safety and effectiveness of ociperlimab combined with tislelizumab and chemotherapy, compared to tislelizumab and chemotherapy alone, in participants with non-small cell lung cancer (NSCLC) that was locally advanced, could not be removed by surgery, or had spread to other parts of the body.
Key facts
- Study ID
- NCT05014815
- Run by
- BeiGene
- People needed
- 272
- Starts
- 2021-11-16
- Expected to finish
- 2024-09-04
- Last updated by the study team
- 2025-09-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Comprehensive Cancer Center of Nevada — Las Vegas, Nevada, United States
- Rj Zuckerberg Cancer Center — New Hyde Park, New York, United States
- North Shore Hematology Oncology Associates Dba New York Cancer and Blood Specialists (New York) — New York, New York, United States
- North Shore Hematology Oncology Associates Dba New York Cancer and Blood Specialists — Port Jefferson Station, New York, United States
- Ny Cancer and Blood Specialists — The Bronx, New York, United States
- Xcancerdayton Physician Network — Dayton, Ohio, United States
- Tennessee Cancer Specialist — Knoxville, Tennessee, United States
- Texas Oncology Tyler Longview — Austin, Texas, United States
- Cancer Care Northwest — Spokane Valley, Washington, United States
- Border Medical Oncology — East Albury, New South Wales, Australia
- Northern Beaches Hospital — Frenchs Forest, New South Wales, Australia
- Port Macquarie Base Hospital — Port Macquarie, New South Wales, Australia
- Townsville University Hospital — Douglas, Queensland, Australia
- Toowoomba Hospital — Toowoomba, Queensland, Australia
- Launceston General Hospital — Launceston, Tasmania, Australia
- Peninsula and South Eastern Haematology and Oncology Group — Frankston, Victoria, Australia
- Olivia Newton John Cancer Wellness and Research Centre — Heidelberg, Victoria, Australia
- Klinik Penzing Wien, Abteilung Fur Atemwegs — Vienna, Austria
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Xinqiao Hospital Affiliated to the Army Medical University — Chongqing, Chongqing Municipality, China
- Daping Hospital, Third Military Medical University — Chongqing, Chongqing Municipality, China
- Fujian Cancer Hospital — Fuzhou, Fujian, China
- The First Hospital of Lanzhou University — Lanzhou, Gansu, China
- Valkyrie Clinical Trials — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.